New oligoclonal band test can predict conversion to multiple sclerosis
Christine Kyme
This article has no abstract so we have provided the first paragraph of the full text.
Patients who experience a clinically isolated syndrome (CIS) frequently go on to develop clinically definite multiple sclerosis (CDMS). For these patients, an accurate prognostic marker of CDMS could allow treatment of their condition to commence earlier. Results of a recent prospective study indicate that a new, highly sensitive method of OLIGOCLONAL IgG BAND (OCGB) detection can accurately predict CIS conversion to CDMS.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
L-DOPA, dyskinesia and striatal plasticityNature Neuroscience News and Views (01 May 2003)